• Statistics

    • In 2008, $141 million was spent on prescription drugs for the treatment of Crohn's disease.
    • The majority of Crohn's disease patients will require hospitalization at some point and more than half will require surgery.
    • Worldwide, there are 177 pharmaceutical products indicated for Crohn's disease and 52 pharmaceutical products in clinical trials.
    • Most patients develop Crohn's disease during their 20s
    • Patients with moderate to severe Crohn's disease have an increased risk of premature death similar to that reported for moderate smokers.
    • More than 40% of Crohn's disease patients have subsequently developed lactose intolerance (50 000 Canadians).

Enhancing lifelong health

The Canadian Digestive Health Foundation believes our ability to help establish, enrich and protect a healthy gut microbiota is the key to lifelong health